All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

NEWSROOM

Corporate

09/06/2022

2021 Financial Statements: Fidia Farmaceutici achieves double-digit growth, with EBITDA exceeding 20% of turnover

Corporate

10/05/2022

Regenerate & Evolve: Fidia Farmaceutici goes online with its new digital brand identity

Our Focus

11/05/2022

Fidia harnesses the regenerative power of hyaluronic acid with its innovative portfolio launched in Spain

Our Focus

13/12/2021

Fidia main sponsor of the inauguration of the first ESASO italian campus